(Q53239832)

English

Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study.

scientific article published on 22 March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17381445

Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17381445

1 reference

based on heuristic

inferred from title

author name string

Marianne Cunnington

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17381445

Sandy Ferber

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17381445

George Quartey

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17381445

International Lamotrigine Pregnancy Registry Scientific Advisory Committee

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17381445

publication date

22 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17381445

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17381445

48

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17381445

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17381445

1207-1210

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17381445

Lamotrigine and the risk of malformations in pregnancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01021.X

21 January 2018

The teratogenicity of anticonvulsant drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01021.X

21 January 2018

Evaluation of selected characteristics of pregnancy drug registries

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01021.X

21 January 2018

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01021.X

21 January 2018

Two-sided confidence intervals for the single proportion: comparison of seven methods

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01021.X

21 January 2018

The impact of pregnancy and childbirth on the metabolism of lamotrigine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01021.X

21 January 2018

Maternal valproate dosage and foetal malformations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01021.X

21 January 2018

Identifiers

10.1111/J.1528-1167.2007.01021.X

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17381445

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17381445

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53239832&oldid=1522802084"